Correspondence: When an article is eligible for submission of
Correspondence, a link to the response form is available within the full-text
article. You must be a
current subscriber who has activated the online portion of your subscription
in order to send a Correspondence. Any reader can read published
Correspondence.
Correspondence to:
ARTICLES:
Glen L. Xiong, Brenda L. Plassman, Michael J. Helms, and David C. Steffens
Vascular risk factors and cognitive decline among elderly male twins
Neurology 2006; 67: 1586-1591
[Abstract][Full text][PDF]
Xiong et al’s elegant study provides valuable data illustrating the
damaging effects of diabetes on cognitive function while minimizing
genetic and early environmental background noise. [1]
Elucidating the
mechanisms underlying the cognitive decline could be facilitated by
examining available imaging data for some of the twin pairs discordant for
diabetes. Addressing the issue of whether accelerated cognitive
dysfunction in twin pairs is always correlated with the accumulation of
brain infarcts on MRI would provide valuable insight into how diabetes
exerts its deleterious effects on cognition.
If non-vascular mechanisms
such as direct glucose toxicity on neurons, enhanced amyloid deposition,
or deranged neurotransmission are shown to play a prominent role in
“diabetic dementia” these may be addressed by the early initiation of
preventative therapies targeted at these factors. As aggressive glycemic
control may be expected to slow cognitive decline by multiple mechanisms,
it would be interesting to know whether there was data available which
allowed this factor to be related to the rate of cognitive deterioration
in this study.
Further application of this twin assessment approach may
provide information regarding the mechanisms underlying the
cognitive decline in this prevalent and potentially disabling condition.
Reference
1. Xiong GL, Plassman BL, Helms MJ, Steffens DC.
Vascular risk factors and cognitive decline among elderly male twins Neurology 2006; 67: 1586-1591.
Disclosure: The author reports no conflicts of interest.
Reply from the authors
1 February 2007
Brenda L. Plassman, Duke University Medical Center 905 W Main Street, Ste 25-D, Box 41, Durham, NC 27701, Glen L. Xiong, Michael J. Helms, David C. Steffens
bplassman{at}psych.duhs.duke.edu Brenda L. Plassman, et al.
We thank Dr. Gotkine for his comments about utilizing
neuroimaging to clarify the mechanism underlying the observed association
between diabetes and cognitive decline. Due to the financial costs of in-person assessments of individuals in this sample who reside throughout the
continental US, much of the data on the NAS-NRC WWII Veteran Twin
Registry was collected via telephone interviews or mail-out
questionnaires.
Unfortunately, this means that we typically do not have
neuroimaging studies to assess cerebrovascular lesions. For this same
reason, we do not have blood samples or detailed medical records available
to assess the level of glycemic control among the diabetics.
We agree
that having sufficiently detailed medical information, blood glucose
levels or an index of diabetes control such as hemoglobin A1C, and
neuroimaging data--perhaps including PET--would be important for future studies.
Disclosure: The authors report no conflicts of interest.